Rights and permissions
About this article
Cite this article
Suboptimal use of mood stabilisers costly in bipolar disorders. Pharmacoecon. Outcomes News 385, 9 (2002). https://doi.org/10.1007/BF03279767
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279767